| Name | Title | Contact Details |
|---|
Omrix Biopharmeceuticals, Inc is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NMT Medical, Inc. is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
It is the vision of Willow Crest hospital to be the provider of choice for patients, family members, and referral sources. We shall strive to exceed expectations of our customers in the provision of high quality, cost effective services.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
BioMS Medical Corporation is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.